UT Health, Ohio company reach license agreement to develop chlamydia vaccine
December 13, 2022
Vaccines for this infection have been challenging to produce UT Health has granted an exclusive global license allowing an Ohio biopharmaceutical company to develop university research discoveries into a novel oral vaccine for chlamydia. According to the U.S. Centers for Disease Control and Prevention (CDC), chlamydia is the bacterial sexually transmitted infection most frequently reported […]
